Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year ...Middle East

The positive results from this preclinical study underscore Ketamir-2's potential as a superior alternative to traditional ketamine Unlike ketamine, which requires intravenous or intranasal administration, Ketamir-2's oral formulation promises ease of use and better patient compliance and...

Hence then, the article about mira pharmaceuticals announces positive preclinical study results for its novel oral ketamine analog ketamir 2 paving the way for ind submission later this year was published today ( Monday 10/06/2024 - 03:32 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year )

Also on site :

• Taiwan’s economy is booming thanks to AI. Not everyone sees the benefits
• SXSW London: Michelle Obama, Claire Foy and Piers Morgan Among Latest Speakers Added to Fest Lineup
• Doing This One Thing on Vacation is Seriously Stressing Your Pets Out